Hubei Guangji Pharmaceutical Co., Ltd. (000952.SZ)
CNY 5.49
(2.23%)
CNY 5.49
(2.23%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 737.81 Million CNY | -7.5% |
| 2022 | 797.64 Million CNY | -4.71% |
| 2021 | 837.1 Million CNY | 21.64% |
| 2020 | 688.16 Million CNY | -5.9% |
| 2019 | 731.34 Million CNY | -13.33% |
| 2018 | 843.83 Million CNY | 5.27% |
| 2017 | 801.55 Million CNY | 12.15% |
| 2016 | 714.72 Million CNY | 27.55% |
| 2015 | 560.35 Million CNY | 15.33% |
| 2014 | 485.85 Million CNY | -0.25% |
| 2013 | 487.08 Million CNY | 23.58% |
| 2012 | 394.15 Million CNY | -13.05% |
| 2011 | 453.31 Million CNY | -6.21% |
| 2010 | 483.31 Million CNY | 7.84% |
| 2009 | 448.19 Million CNY | -21.61% |
| 2008 | 571.78 Million CNY | -28.07% |
| 2007 | 794.9 Million CNY | 104.51% |
| 2006 | 388.69 Million CNY | 12.39% |
| 2005 | 345.83 Million CNY | 25.02% |
| 2004 | 276.62 Million CNY | 35.54% |
| 2003 | 204.09 Million CNY | 0.96% |
| 2002 | 202.15 Million CNY | 8.63% |
| 2001 | 186.09 Million CNY | 38.73% |
| 2000 | 134.14 Million CNY | -24.03% |
| 1999 | 176.57 Million CNY | 9.46% |
| 1998 | 161.31 Million CNY | 14.21% |
| 1997 | 141.23 Million CNY | 22.94% |
| 1996 | 114.88 Million CNY | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q3 | 162.34 Million CNY | 42.51% |
| 2024 Q1 | 180.16 Million CNY | -16.33% |
| 2024 Q2 | 116.29 Million CNY | -35.45% |
| 2023 Q3 | 178.58 Million CNY | -21.89% |
| 2023 Q4 | 215.32 Million CNY | 20.57% |
| 2023 Q1 | 115.29 Million CNY | -55.89% |
| 2023 FY | 737.81 Million CNY | -7.5% |
| 2023 Q2 | 228.62 Million CNY | 98.3% |
| 2022 FY | 797.64 Million CNY | -4.71% |
| 2022 Q4 | 261.36 Million CNY | 61.73% |
| 2022 Q1 | 178.87 Million CNY | -50.42% |
| 2022 Q2 | 334 Million CNY | 86.73% |
| 2022 Q3 | 161.6 Million CNY | -51.62% |
| 2021 FY | 837.1 Million CNY | 21.64% |
| 2021 Q1 | 176.32 Million CNY | 0.62% |
| 2021 Q2 | 146.98 Million CNY | -16.64% |
| 2021 Q3 | 153.02 Million CNY | 4.11% |
| 2021 Q4 | 360.77 Million CNY | 135.76% |
| 2020 FY | 688.16 Million CNY | -5.9% |
| 2020 Q4 | 175.24 Million CNY | 1.85% |
| 2020 Q2 | 207.44 Million CNY | 55.48% |
| 2020 Q3 | 172.05 Million CNY | -17.06% |
| 2020 Q1 | 133.42 Million CNY | -24.19% |
| 2019 Q1 | 180.91 Million CNY | -23.31% |
| 2019 Q3 | 189.85 Million CNY | 2.86% |
| 2019 Q4 | 175.99 Million CNY | -7.3% |
| 2019 FY | 731.34 Million CNY | -13.33% |
| 2019 Q2 | 184.57 Million CNY | 2.02% |
| 2018 Q1 | 244.84 Million CNY | 7.86% |
| 2018 FY | 843.83 Million CNY | 5.27% |
| 2018 Q4 | 235.9 Million CNY | 13.85% |
| 2018 Q3 | 207.2 Million CNY | 32.92% |
| 2018 Q2 | 155.88 Million CNY | -36.34% |
| 2017 Q4 | 226.99 Million CNY | 5.56% |
| 2017 FY | 801.55 Million CNY | 12.15% |
| 2017 Q1 | 170.47 Million CNY | 6.32% |
| 2017 Q2 | 189.03 Million CNY | 10.89% |
| 2017 Q3 | 215.04 Million CNY | 13.76% |
| 2016 Q1 | 156.71 Million CNY | -15.1% |
| 2016 Q2 | 160.19 Million CNY | 2.22% |
| 2016 Q4 | 160.33 Million CNY | -32.48% |
| 2016 FY | 714.72 Million CNY | 27.55% |
| 2016 Q3 | 237.47 Million CNY | 48.24% |
| 2015 Q4 | 184.58 Million CNY | -3.24% |
| 2015 FY | 560.35 Million CNY | 15.33% |
| 2015 Q3 | 190.77 Million CNY | 125.22% |
| 2015 Q2 | 84.7 Million CNY | -15.55% |
| 2015 Q1 | 100.3 Million CNY | -4.86% |
| 2014 FY | 485.85 Million CNY | -0.25% |
| 2014 Q4 | 105.42 Million CNY | -29.71% |
| 2014 Q3 | 149.98 Million CNY | 7.68% |
| 2014 Q2 | 139.28 Million CNY | 52.8% |
| 2014 Q1 | 91.15 Million CNY | -26.8% |
| 2013 FY | 487.08 Million CNY | 23.58% |
| 2013 Q4 | 124.53 Million CNY | -7.74% |
| 2013 Q3 | 134.98 Million CNY | 13.21% |
| 2013 Q2 | 119.23 Million CNY | 10.06% |
| 2013 Q1 | 108.33 Million CNY | 25.19% |
| 2012 FY | 394.15 Million CNY | -13.05% |
| 2012 Q1 | 114.82 Million CNY | 39.35% |
| 2012 Q3 | 92.27 Million CNY | -8.21% |
| 2012 Q2 | 100.52 Million CNY | -12.45% |
| 2012 Q4 | 86.53 Million CNY | -6.22% |
| 2011 Q2 | 128.33 Million CNY | 2.24% |
| 2011 Q1 | 125.52 Million CNY | 12.12% |
| 2011 FY | 453.31 Million CNY | -6.21% |
| 2011 Q4 | 82.4 Million CNY | -29.61% |
| 2011 Q3 | 117.06 Million CNY | -8.78% |
| 2010 Q3 | 104.72 Million CNY | -18.89% |
| 2010 Q4 | 111.95 Million CNY | 6.9% |
| 2010 FY | 483.31 Million CNY | 7.84% |
| 2010 Q1 | 137.51 Million CNY | 14.53% |
| 2010 Q2 | 129.11 Million CNY | -6.11% |
| 2009 Q2 | 104.52 Million CNY | 9.42% |
| 2009 Q4 | 120.07 Million CNY | -6.24% |
| 2009 FY | 448.19 Million CNY | -21.61% |
| 2009 Q3 | 128.06 Million CNY | 22.52% |
| 2009 Q1 | 95.52 Million CNY | 44.8% |
| 2008 FY | 571.78 Million CNY | -28.07% |
| 2008 Q4 | 65.97 Million CNY | -50.85% |
| 2008 Q3 | 134.21 Million CNY | -27.67% |
| 2008 Q2 | 185.57 Million CNY | -0.24% |
| 2008 Q1 | 186.02 Million CNY | -32.7% |
| 2007 Q3 | 254.47 Million CNY | 79.08% |
| 2007 Q4 | 276.42 Million CNY | 8.63% |
| 2007 Q2 | 142.09 Million CNY | 16.56% |
| 2007 Q1 | 121.9 Million CNY | 17.96% |
| 2007 FY | 794.9 Million CNY | 104.51% |
| 2006 Q1 | 88.8 Million CNY | -8.67% |
| 2006 Q2 | 102.24 Million CNY | 15.13% |
| 2006 Q3 | 94.29 Million CNY | -7.77% |
| 2006 Q4 | 103.35 Million CNY | 9.6% |
| 2006 FY | 388.69 Million CNY | 12.39% |
| 2005 FY | 345.83 Million CNY | 25.02% |
| 2005 Q2 | 87.87 Million CNY | 20.93% |
| 2005 Q4 | 97.23 Million CNY | 10.43% |
| 2005 Q1 | 72.67 Million CNY | -14.16% |
| 2005 Q3 | 88.05 Million CNY | 0.2% |
| 2004 FY | 276.62 Million CNY | 35.54% |
| 2004 Q4 | 84.65 Million CNY | 27.9% |
| 2004 Q3 | 66.18 Million CNY | 6.14% |
| 2004 Q1 | 63.41 Million CNY | 3.98% |
| 2004 Q2 | 62.36 Million CNY | -1.66% |
| 2003 Q4 | 60.98 Million CNY | 35.15% |
| 2003 Q2 | 44.32 Million CNY | -17.39% |
| 2003 FY | 204.09 Million CNY | 0.96% |
| 2003 Q1 | 53.65 Million CNY | 3.78% |
| 2003 Q3 | 45.12 Million CNY | 1.81% |
| 2002 Q1 | 40.83 Million CNY | 0.0% |
| 2002 Q4 | 51.7 Million CNY | 2.87% |
| 2002 Q3 | 50.25 Million CNY | -15.35% |
| 2002 Q2 | 59.36 Million CNY | 45.41% |
| 2002 FY | 202.15 Million CNY | 8.63% |
| 2001 FY | 186.09 Million CNY | 38.73% |
| 2000 FY | 134.14 Million CNY | -24.03% |
| 1999 FY | 176.57 Million CNY | 9.46% |
| 1998 FY | 161.31 Million CNY | 14.21% |
| 1997 FY | 141.23 Million CNY | 22.94% |
| 1996 FY | 114.88 Million CNY | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Zhejiang Int'l Group Co.,Ltd. | 32.05 Billion CNY | 97.698% |
| Zhejiang Zhenyuan Share Co., Ltd. | 4.1 Billion CNY | 82.032% |
| Hunan Jingfeng Pharmaceutical Co.,Ltd. | 656.89 Million CNY | -12.319% |
| Yifan Pharmaceutical Co., Ltd. | 4.02 Billion CNY | 81.656% |
| Guangdong Jiaying Pharmaceutical Co., Ltd | 533.23 Million CNY | -38.367% |
| Sichuan Kelun Pharmaceutical Co., Ltd. | 21.15 Billion CNY | 96.512% |
| Chongqing Lummy Pharmaceutical Co., Ltd. | 895.59 Million CNY | 17.617% |
| Boai NKY Medical Holdings Ltd. | 1.58 Billion CNY | 53.403% |
| Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. | 848.19 Million CNY | 13.013% |